Comparable to any profit-maximizing firm, a monopoly produces the quantity of output in the short run that maximizes the difference between total revenue with total cost, which is economic profit. At this production level, the monopoly cannot increase profit by changing the level of production. The analysis of total revenue and total cost can be achieved through a table of numbers or with total revenue and total cost curves.

Working the Numbers

Because Feet-First Pharmaceutical produces a unique product it has extensive market control and sells its Amblathan-Plus according to the market demand. To sell a larger quantity, it must lower the price. Feet-First Pharmaceutical's status as a monopoly firm is reflected in this table.

The Numbers

• Quantity: The quantity of output produced by the Feet-First Pharmaceutical, presented in the first column, ranges from 0 to 12 ounces of Amblathan-Plus. While, Feet-First Pharmaceutical could produce more than 12 ounces, this range is sufficient for the present analysis.


• Price: The second column presents the price received by Feet-First Pharmaceutical for selling Amblathan-Plus. As a price maker, the first and second columns represent the market demand for Amblathan-Plus. The price Feet-First Pharmaceutical faces ranges from a high of $10.50 per ounce for a zero quantity to a low of $4.50 per ounce for 12 ounces. Feet-First Pharmaceutical can sell a larger quantity of Amblathan-Plus, but only by reducing the price. Feet-First Pharmaceutical is a price maker.


• Total Revenue: Total revenue is presented in the third column. This indicates the revenue Feet-First Pharmaceutical receives at each level of Amblathan-Plus production. It is derived as the quantity in the first column multiplied by the price in the second column. Total revenue ranges from $0 if no output is sold to a high of $55 for selling 10 or 11 ounces of Amblathan-Plus. For example, selling 4 ounces of Amblathan-Plus generates $34 of revenue and selling 7 ounces leads to $49 of revenue.


• Total Cost: The fourth column presents the total cost incurred by Feet-First Pharmaceutical in the production of Amblathan-Plus, ranging from a low of $10 for zero output (which is fixed cost) to a high of $117 for 12 ounces. Total cost continues to rise beyond 12 ounces, but this information is not needed. Producing 1 ounce of Amblathan-Plus incurs a total cost of $17. Producing 2 ounces of Amblathan-Plus incurs a total cost of $22. Total cost rises as Feet-First Pharmaceutical produces more.


• Profit: The fifth column at the far right of the table is available to display economic profit, the difference between total revenue in the third column and total cost in the fourth column. A click of the [Profit] button displays Feet-First Pharmaceutical's economic profit in the fifth column.

A click of the [Incurring Losses] button indicates that producing and selling 1 ounce of Amblathan-Plus generates an economic loss of $7. Total revenue is $10 and total cost is $17. A $3 loss results from 2 ounces of Amblathan-Plus. Feet-First Pharmaceutical incurs an economic loss for the first 2 ounces of Amblathan-Plus. Feet-First Pharmaceutical also incurs an economic loss if production is 9 ounces or more.

But loss is not what Feet-First Pharmaceutical seeks. Click the [Earning Profits] button to highlight the range of production levels that generate positive economic profit. Feet-First Pharmaceutical initially turns its profit picture around with 3 ounces of Amblathan-Plus. At 3 ounces of Amblathan-Plus Feet-First Pharmaceutical's total revenue is greater than his total cost by $1. Profit remains positive through the production of 8 ounces of Amblathan-Plus, Feet-First Pharmaceutical's total revenue exceeds total cost and it receives an economic profit. For 5 ounces of Amblathan-Plus, this profit is $7, for 6 ounces profit is $8, and for 7 ounces profit drops back to $7 again.

So what is the profit-maximizing level of Amblathan-Plus production Feet-First Pharmaceutical should undertake? The desired production level is clearly not 2 ounces or less, nor is it 9 ounces or more, all of which lead to economic loss. It must be within the highlighted range between 3 and 8.

The quantity that generates the greatest of economic profit is 6 ounces of Amblathan-Plus. This alternative can be highlighted by clicking the [Profit Max] button. The production of 6 ounces of Amblathan-Plus results in $45 of total revenue and $37 of total cost, a difference of $8. No other production level generates a greater economic profit. Producing 1 more ounce of Amblathan-Plus or 1 less ounce of Amblathan-Plus reduces profit to $7.

Working the Curves

The Amblathan-Plus Curves

• Total Revenue: A click of the [Total Revenue] button reveals a hump-shaped green line labeled TR that depicts the total revenue that Feet-First Pharmaceutical receives from Amblathan-Plus production and sales. The line is hump-shaped because Feet-First Pharmaceutical faces a negatively-sloped demand curve.


• Total Cost: A click of the [Total Cost] button reveals a curvy red line labeled TC represents the total cost that Feet-First Pharmaceutical incurs in the production of Amblathan-Plus. The shape is based on increasing, then decreasing marginal returns.


• Profit: The vertical difference between these two lines is economic profit. If the total revenue line is above the total cost line in the middle of the diagram, economic profit is positive. If the total revenue line is below the total cost line at the far right and far left, economic profit is negative.

Before leaving this graph, two other quantities can be highlighted. The total revenue and total cost curves intersect at two quantities--at just under 3 ounces of Amblathan-Plus and about 8.5 ounces of Amblathan-Plus. Click the [Breakeven] button to highlight these two output levels.